Organon & Co. (OGN)

USD 12.03

(4.66%)

Inventory Summary of Organon & Co.

  • Organon & Co.'s latest annual inventory in 2023 was 1.31 Billion USD , up 31.11% from previous year.
  • Organon & Co.'s latest quarterly inventory in 2024 Q2 was 1.28 Billion USD , up 1.9% from previous quarter.
  • Organon & Co. reported annual inventory of 1 Billion USD in 2022, up 9.62% from previous year.
  • Organon & Co. reported annual inventory of 915 Million USD in 2021, up 0.22% from previous year.
  • Organon & Co. reported quarterly inventory of 1.38 Million USD for 2024 Q3, up 7.46% from previous quarter.
  • Organon & Co. reported quarterly inventory of 1.28 Billion USD for 2024 Q2, up 1.9% from previous quarter.

Annual Inventory Chart of Organon & Co. (2023 - 2018)

Historical Annual Inventory of Organon & Co. (2023 - 2018)

Year Inventory Inventory Growth
2023 1.31 Billion USD 31.11%
2022 1 Billion USD 9.62%
2021 915 Million USD 0.22%
2020 913 Million USD -14.75%
2019 1.07 Billion USD 7.75%
2018 994 Million USD 0.0%

Peer Inventory Comparison of Organon & Co.

Name Inventory Inventory Difference
AbbVie Inc. 4.09 Billion USD 67.919%
Bristol-Myers Squibb Company 2.66 Billion USD 50.601%
Bristol-Myers Squibb Company Ce 2.66 Billion USD 50.601%
Johnson & Johnson 11.18 Billion USD 88.239%
Eli Lilly and Company 5.77 Billion USD 77.221%
Merck & Co., Inc. 6.35 Billion USD 79.317%
Novartis AG 5.91 Billion USD 77.761%
Pfizer Inc. 10.18 Billion USD 87.094%